Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Sales | 110,649 | 102,628 | 92,256 | 81,267 | 77,399 |
| Cost of Goods | 12,892 | 11,895 | 10,313 | 9,959 | 6,812 |
| Gross Profit | 97,757 | 90,733 | 81,943 | 71,308 | 70,587 |
| Operating Expenses | 75,994 | 63,741 | 61,306 | 56,700 | 54,876 |
| Operating Income | 22,655 | 27,887 | 20,950 | 15,567 | 16,523 |
| Interest Expense | 84 | 80 | 109 | 333 | 441 |
| Other Income | 23 | -125 | -2,947 | -90 | 665 |
| Pre-tax Income | 22,594 | 27,682 | 17,894 | 15,144 | 16,747 |
| Income Tax | -214,533 | 951 | 1,092 | 638 | 1,412 |
| Net Income Continuous | 237,127 | 26,731 | 16,802 | 14,506 | 15,335 |
| Net Income | $237,127 | $26,731 | $16,802 | $14,506 | $15,335 |
| EPS Basic Total Ops | 1.39 | 0.16 | 0.10 | 0.09 | 0.10 |
| EPS Basic Continuous Ops | 1.39 | 0.15 | 0.10 | 0.09 | 0.10 |
| EPS Diluted Total Ops | 1.31 | 0.15 | 0.10 | 0.08 | 0.10 |
| EPS Diluted Continuous Ops | 1.31 | 0.15 | 0.09 | 0.08 | 0.09 |
| EBITDA(a) | $26,193 | $30,858 | $23,890 | $18,591 | $18,602 |